HK Stock Market Move | MEDBOT-B(02252) rose more than 13% in early trading, with total orders exceeding 100 units. International business has achieved rapid growth.

MEDBOT-B(02252) rose over 13% in the morning session, rising 11.92% to HK$11.64 as of press time, with a trading volume of HK$168 million. On the news front, Siasun Robot&Automation recently revealed that the company's comprehensive order volume has exceeded 100 units, with the global orders for 2024 reaching 39 units and commercial installations surpassing 30 units. The global cumulative commercial orders are close to 60 units, with rapid growth in international business. In addition, in 2024, Siasun Robot&Automation's Honghu unit has 25 global orders, surpassing 40 cumulative orders. R-ONE has become the only coronary intervention surgery Siasun Robot&Automation product currently listed and sold domestically. China Securities Co., Ltd. points out that Siasun Robot&Automation is expected to achieve certain sales growth in China in 2024; it has achieved good breakthroughs overseas in 2023 and 2024, and is expected to obtain registration certificates in more regions in 2025 and achieve more installations under the synergy of the Minimally Invasive Group.